MedTrace Logo

Open-label Safety and Tolerability Study of LTS-PDT in Healthy Volunteers

NCT01830764 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2021-07-20

No results posted yet for this study

Summary

The purpose of this study is assess the safety and tolerability of lemuteporfin topical solution (LTS) with exposure to red light (PDT), when applied to the backs of healthy volunteers.

Conditions

  • Acne Vulgaris

Interventions

DRUG

Red Light (PDT)

LTS, 0.3% applied topically followed by red light dose (75 J/cm2 or 150 J/cm2)

Sponsors & Collaborators

  • Dermira, Inc.

    lead INDUSTRY

Principal Investigators

  • Jonathan S Dosik, MD · TKL Research Inc (Research Clinics Division)

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01830764 on ClinicalTrials.gov